Michael D. West - Mar 11, 2023 Form 4 Insider Report for AgeX Therapeutics, Inc. (AGE)

Role
Chief Executive Officer
Signature
/s/Michael D. West
Stock symbol
AGE
Transactions as of
Mar 11, 2023
Transactions value $
-$625
Form type
4
Date filed
3/14/2023, 09:32 PM
Previous filing
Dec 13, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AGE Common Stock, $0.0001 par value Options Exercise $0 +3.13K +7.83% $0.00 43K Mar 11, 2023 Direct F1
transaction AGE Common Stock, $0.0001 par value Tax liability -$625 -1.06K -2.46% $0.59 42K Mar 11, 2023 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AGE Restricted Stock Units Options Exercise $0 -3.13K -100% $0.00* 0 Mar 11, 2023 Common Stock 3.13K $0.00 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Excludes shares owned by former spouse of which Dr. West disclaims beneficial ownership.
F2 Securities withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 3,125 Restricted Stock Units, the grant of which was previously reported on a Form 4.
F3 Restricted Stock Units vested on March 11, 2023.